Literature DB >> 18312791

Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.

Hyun Jik Kim1, Hyung Ju Cho, Kyung Soo Kim, Hun Suk Lee, Heui-Jong Kim, Euisok Jung, Joo-Heon Yoon.   

Abstract

INTRODUCTION: Olfactory neuroblastoma is a very aggressive tumour with high rates of locoregional recurrence and distant metastasis. Therefore, salvage therapy plays an important role in control of these neoplasms. In this study, we present our experience and treatment outcomes for salvage therapy in patients with recurrent olfactory neuroblastoma.
MATERIAL AND METHODS: We retrospectively analysed 17 patients treated for advanced olfactory neuroblastoma during the last 15 years.
RESULTS: The disease-free 5-year survival rate was 48% in all patients and 42% in the 17 patients with recurrence or distant metastasis. Salvage therapy was performed in 6 of 8 patients with recurrence or metastasis and proved successful in 50% of them. In the patients with locoregional recurrence, the success rate of salvage radiotherapy plus neck dissection was superior to salvage chemotherapy alone. In addition, 17% of the patients with distant metastasis after initial treatment died after salvage therapy. In 15% of patients with a clinical stage N0 at initial diagnosis, nodal recurrence developed and was successfully treated with salvage therapy.
CONCLUSION: Complete surgical resection, including craniofacial resection and postoperative radiotherapy without elective neck dissection, is the preferred approach in the treatment of advanced olfactory neuroblastoma. In locoregional recurrence, successful salvage therapy may include selective neck dissection and radiotherapy, but in cases of distant metastasis, the prognosis was poor.

Entities:  

Mesh:

Year:  2008        PMID: 18312791     DOI: 10.1016/j.jcms.2007.08.004

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  8 in total

Review 1.  Long-term carcinologic results of advanced esthesioneuroblastoma: a systematic review.

Authors:  Guillaume De Bonnecaze; B Lepage; J Rimmer; A Al Hawat; B Vairel; E Serrano; B Chaput; S Vergez
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-17       Impact factor: 2.503

2.  Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma: A Multicenter Study.

Authors:  Jamie J Van Gompel; Michael J Link; Jason P Sheehan; Zhiyuan Xu; David Mathieu; Hideyuki Kano; L Dade Lunsford
Journal:  J Neurol Surg B Skull Base       Date:  2014-06-04

3.  The developing management of esthesioneuroblastoma: a single institution experience.

Authors:  Leif Bäck; Minna Oinas; Petra Pietarinen-Runtti; Kauko Saarilahti; Jyrki Vuola; Riste Saat; Juha Öhman; Caj Haglund; Mika Niemelä; Ilmo Leivo; Jaana Hagström; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-15       Impact factor: 2.503

Review 4.  Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.

Authors:  Daniel B Spielman; Andi Liebowitz; Maeher Grewal; Chetan Safi; Jonathan B Overdevest; Alfred M Iloreta; Brett E Youngerman; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22

5.  The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Authors:  Wen Jiang; Abdallah S R Mohamed; Clifton David Fuller; Betty Y S Kim; Chad Tang; G Brandon Gunn; Ehab Y Hanna; Steven J Frank; Shirley Y Su; Eduardo Diaz; Michael E Kupferman; Beth M Beadle; William H Morrison; Heath Skinner; Stephen Y Lai; Adel K El-Naggar; Franco DeMonte; David I Rosenthal; Adam S Garden; Jack Phan
Journal:  Pract Radiat Oncol       Date:  2015-11-10

6.  Unexpectedly durable palliation of metastatic olfactory neuroblastoma using anti-angiogenic therapy with Bevacizumab.

Authors:  Erin M Dunbar; Phyllis K Pumphrey; Sharat Bidari
Journal:  Rare Tumors       Date:  2012-06-12

7.  Delaying Postoperative Radiotherapy in Low-Grade Esthesioneuroblastoma: Is It Worth the Wait?

Authors:  Satoshi Kiyofuji; Vijay Agarwal; Joshua D Hughes; Robert L Foote; Jeffrey R Janus; Eric J Moore; Caterina Giannini; Michael J Link; Jamie J Van Gompel
Journal:  J Neurol Surg B Skull Base       Date:  2020-03-25

8.  Subfrontal schwannoma mimicking neuroblastoma: case report.

Authors:  Hitoshi Yamahata; Kazuho Hirahara; Tetsuzou Tomosugi; Masahiko Yamada; Takeshi Ishii; Takashi Ishigami; Koichi Uetsuhara; Kazunobu Sueyoshi; Sumika Matsukida; Kazutaka Yatsushiro; Kazunori Arita
Journal:  Skull Base Rep       Date:  2011-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.